North America Stem Cell Assay Market Forecast 2017-2025
The North America stem cell assay market is expected to grow $1082 million by 2025. The market growth is expected at the CAGR of 21.69% in the forecast period. The base year considered for the market study is 2016. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the North America stem cell assay market.
The North America stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The North America stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of North America stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The North America stem cell assay market by geography is segmented into US, Canada, and rest of North America. Increasing Adoption of Stem Cell Assay, improvement in the Technology, high expense in Stem Cell Research are the major drivers for the market growth in North America region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research